Intarcia Therapeutics

Quote


















anonymous said:
Why would you think you could TRUST anyone? Don't you know that when things are written on the walls here, that just means the opposite? See that wall about politics being stamped out. I cant walk by that one without laughing out loud.
Click to expand...

Trust has been #1 creedo at Intarcia because there is NONE from the very top to the bottom.

They trust people so much that the managers listen-in to conference calls with partners and suppliers without disclosing themselves and plant their spies to report back on what was discussed individually or in meetings. Another joke is stamping out politics as it starts on top. Irony is that this place got to be the WORST in terms of how messy the politics are with constant in-fightings and undermining of each other. Worst offenders are the ULT and their moles. Pathetic trust and politics went downhill this year after ULT and BoD departures right before the CRL.

Oh I hate being stuck here and can't wait to bail ASAP.
 






The company is fucked. Hayward will suck most of the money. The device is a bust as they cannot control what comes out of it. Little chance to fix it. More expensive clinical trials probably. My guess the boston teams get canned soon. But consultants like fatty will stay. Simple math guys. Send CVs out.
 






anonymous said:
Trust has been #1 creedo at Intarcia because there is NONE from the very top to the bottom.

They trust people so much that the managers listen-in to conference calls with partners and suppliers without disclosing themselves and plant their spies to report back on what was discussed individually or in meetings. Another joke is stamping out politics as it starts on top. Irony is that this place got to be the WORST in terms of how messy the politics are with constant in-fightings and undermining of each other. Worst offenders are the ULT and their moles. Pathetic trust and politics went downhill this year after ULT and BoD departures right before the CRL.

Oh I hate being stuck here and can't wait to bail ASAP.
Click to expand...
 







The distrust comes from KG and JS.The constant politics and petty discussions. JS actually controls KG, while KG thinks he is controlling JS. Go fucking figure.JS feeds him all the BS that he knows KG will react to and he DOES. No wonder people HATE JS. He also has the worst reputation in the industry.NO ONE follows him from his previous jobs! Recruiters who specialize in sales jobs say this. I know as I talk to them all the time.
 






JS got to be the biggest asshole and douchebag. No wonder he is hated by just about everyone. JS being KG's trusted pal says it all... Cross JS inadvertently over pettiest things and expect the most loathsome loser to come after people.

JS - there is God and trash like you will face judgement, soon, real soon.
 






anonymous said:
The company is fucked. Hayward will suck most of the money. The device is a bust as they cannot control what comes out of it. Little chance to fix it. More expensive clinical trials probably. My guess the boston teams get canned soon. But consultants like fatty will stay. Simple math guys. Send CVs out.
Click to expand...

Heard that the core technology and IP Medici drug delivery pump is fucked. ITCA pushes out the drug by salt tablet dissolved by the body fluid. Trouble is that it’s not controlled release and there is no in-vitro data to buttress or characterize the drug delivery. Duh - what the fuck were the device people doing? Anyway, it may not be a quick fix and throws monkey wrench into the Ph III studies, OUCH! Maybe they can improve the pump but that will take a long time and FDA will probably demand bridging study which means another Ph III trials! We’re talking about 2+ years!!!! Fuck – this is truly a nightmare situation.

So there you go Intarcia employees as more info from CRL is being leaked and it is the worst case. Don’t listen to what the ULT say. Expect the shit canning soon across the board and agree that it will start in Boston.
 






Hold on Wilbur that's not exactly correct. It is well known that as osmotic pressure lessens the release becomes nonlinear - at the end less drug per day then the beginning. That's why the "one year pump" is not being used in any trials. Reality is that changing the pump every three months ensures linear delivery. So we are in good shape as a four times a year pump.
 












anonymous said:
Hold on Wilbur that's not exactly correct. It is well known that as osmotic pressure lessens the release becomes nonlinear - at the end less drug per day then the beginning. That's why the "one year pump" is not being used in any trials. Reality is that changing the pump every three months ensures linear delivery. So we are in good shape as a four times a year pump.
Click to expand...

Yeah genius scientist so the delivery of drug in NONLINEAR meaning exenatide might get dumped all at once or none at all at the extremes and questionable PK since every pump is individually made unlike the drug from same batch or tank?

In the mean time KG touted the non-existent 1-year pump all along and now even the 6-month pump is out of scope? What about the cost to the payors with 1 pump and 2 implant/explant surgeries every 3 months? So much for the no brainer compliance song and dance? Guess y'all believe in Santa Claus, schmucks?
 












LOL the valuation you say? It's all paper guesstimate and for Intarcia more like toilet paper.

Let's see series E investors got snookered into it months before the NDA filing let alone the dreaded CRL? And non-existent made up anti-AIDS product?

Now why did at least 2 US investors sold their stakes to Chinese investors in 2016 if things were so damn rosy? Heck these 2 investors almost forced KG into IPO early?

Why are most unicorns not doing IPO? And what about the IPO haircuts from dying unicorns like snapchat and blue apron? And what about 30% haircut uber investors were forced to accept recently?

SoftBank wants to pay 30% less for Uber stock than Uber's recent $69 billion valuation. Japan's SoftBank is planning to buy stock in Uber from existing shareholders at a steep discount to the ride-hailing company's current valuation, according to a Bloomberg report citing anonymous sources on Monday.Nov 28, 2017
 






Intarcia will be the biggest ever ! Four Times Bigger than the Biggest IPO Ever !



The 29 Year Old Behind The Giant Biotech IPO That Rose By 90% Speaks
This morning, a company that did not exist last summer had the biggest U.S. biotech IPO ever. Axovant Sciences sold shares at $15 a piece, raising $315 million at a $1.4 billion valuation.

Intarcia will IPO in 2019 at a valuation of over $5.
Nathan Vardi , FORBES STAFF Following the money trail
 












"Where Performance Plan Directors and Managers who were fired come to play"

Current Employee - Anonymous Employee

Pros
A paycheck . It’s location is great as well because you can easily access most freeway and bridges. Nothing much more beyond that.

Cons
Too many to list . They thrive of nepotism, harassment and bullying to name a few. Too many social degenerates and misfits under one roof . The bad reputation Intarcia has supersedes itself. Most all directors and managers come disgruntled and or on the verge of being fired from previous roles. Nearly every director there can’t manage and therefore hired outside help to sort out issues they should be able to tackle.

Every director and senior manager there hates the current climate because they are led by VPs who also know the place won’t get approval by the FDA. Worst organization to date in the Bay Area . Nearly the whole staff is one race and or some odd ball who is not an American citizen . The Human Resources department is a sham as well ; they enable unprofessional , immoral and harassing upper managers to perception manage themselves .

Mostly nobody wants to be there. They have no incentive and will never be approved until they dismantle the Good old boys clubs there which Consists Of purely southeast Asian males (Indians).

Folks do NOT come here even for a moment thinking this is a skill set builder or it pays more than most organizations . Intarcia is going nowhere fast . Hopefully they shut the doors soon only worry is that half the rats they currently have as so called directors will jump ship and title surf at other companies

Advice to Management
Your moral depravity will make you fail
 






"Exciting at face value; dig deeper"

Pros
Very promising product and stellar values (on paper), charismatic CEO, beautiful offices.

Cons
Rife with politics, nepotism and ego. Severely understaffed. Many people in power have no experience in the pharmaceutical industry. Despite millions in funding, budgets are stalled.

Advice to Management
You have only one chance to launch a product. After more than 10 years you're no longer a start-up, so don't claim to be one. Don't let your egos obstruct your stated vision. Listen to those with experience.
 






"Great place to work, but some management are morale killers"

Pros
Great technology that will change how the world treats chronic illnesses. Great camaraderie among those who are "in the trenches". Excellent opportunity to get involved in many aspects of a growing the company.

Cons
Too many director level and above management, and not enough working hands-on in the critical areas. Some long-term management in Boston gets scrutiny, but long term finance management in Hayward are extremely difficult to work with and are morale killers. They get away with it despite the "Respect" that the CEO asks us all to live by. The rules don't apply for some reason.

Advice to Management
Issues with Hayward management has always been a top issue on employee surveys, but nothing has changed. Listen to your numerous surveys, find, and deal with the issue.
 












Top Bottom
Back
Quote